Talis Biomedical Investor Relations Material
Latest events
Q2 2023
Talis Biomedical
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Talis Biomedical Corp
Access all reports
Talis Biomedical Corp is a molecular diagnostic company focused on health and patient outcomes through the development and delivery of accurate infectious disease testing at the point of care. The company's efforts are concentrated on diagnosing infectious diseases rapidly, accurately, and directly at the point-of-care. Their product development includes the Talis One system, designed to overcome the limitations of existing point-of-care diagnostic testing technologies, with applications in respiratory infections, women's health infections, sexually transmitted infections, and more. The company is headquartered in Redwood City, California and its shares are listed on the Nasdaq.
Latest articles
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
TLIS
Country
🇺🇸 United States